Rosiglitazone and insulin resistance in renally impaired patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Insulin resistance
- Focus Pharmacodynamics
- 02 Oct 2008 Biomarkers information updated
- 01 Oct 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Jun 2007 New trial record.